ClinConnect ClinConnect Logo
Search / Trial NCT04871399

Complete Mesocolic Excision in Comparison With Conventional Surgery for the Right Colon Cancer

Launched by UNIVERSITY OF TURIN, ITALY · Apr 28, 2021

Trial Information

Current as of July 26, 2025

Recruiting

Keywords

Colon Cancer Right Colon Cancer Complete Mesocolic Excision Cme Right Hemicolectomy Right Colectomy

ClinConnect Summary

This clinical trial is looking at a type of surgery called Complete Mesocolic Excision (CME) to see how it compares to conventional surgery for patients with cancer in the right side of the colon. The goal is to find out if CME can improve outcomes for those needing surgery for this type of cancer. The trial is currently recruiting participants, specifically adults aged 65 to 85 who have a confirmed diagnosis of right colon cancer that has not spread to other parts of the body.

To be eligible for this trial, participants need to be in good overall health (graded I-III by the American Society of Anesthesiologists) and must provide informed consent. Certain individuals, such as those over 85 years old, those with obesity (BMI over 30), or those with other specific medical conditions, may not qualify. If you join the study, you will undergo either the CME procedure or the standard surgery and will be monitored closely to understand the effects of each method. This trial could help improve treatment options for future patients with similar conditions.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • American Society of Anesthesiologists(ASA) grade I-III.
  • Right colon cancer (\*The right-sided location of the cancer is defined as the location from the caecum up to the proximal third of the transverse colon), preoperative assessment of tumor stage T2-T4a, any N or T any N+ according to the National Comprehensive Cancer Network(NCCN) clinical practice guidelines in oncology: colon cancer version 2.2015); no distant metastasis.
  • Informed consent
  • Exclusion Criteria:
  • Age \> 85 years old.
  • T1, N0
  • T4b, any N
  • BMI \> 30.
  • Metastatic disease (Abdominal and chest CT scan will be mandatory to exclude distant metastasis.)
  • American Society of Anesthesiologists(ASA) grade IV.
  • History of cancer in recent 5 years.
  • Need for Emergency surgery.
  • Infectious disease requiring treatment.
  • Pregnancy.
  • Use of systemic steroids.
  • No history of familial adenomatous polyposis, ulcerative colitis or Crohn's disease.

About University Of Turin, Italy

The University of Turin, located in Italy, is a prestigious academic institution renowned for its commitment to research and innovation in the medical field. As a clinical trial sponsor, the university leverages its extensive expertise and resources to advance scientific knowledge and improve patient outcomes. Collaborating with a network of healthcare professionals and researchers, the University of Turin conducts rigorous clinical trials that adhere to the highest ethical and regulatory standards. Its focus on translational research ensures that findings contribute to the development of effective therapies and healthcare solutions, enhancing the overall well-being of diverse populations.

Locations

Milano, , Italy

Rome, , Italy

Genova, , Italy

Rome, , Italy

Grosseto, Arezzo, Italy

Sesto San Giovanni, Milano, Italy

La Spezia, Spezia, Italy

Candiolo, Torino, Italy

Pinerolo, Torino, Italy

Bologna, , Italy

Ferrara, , Italy

Messina, , Italy

Napoli, , Italy

Torino, , Italy

Patients applied

0 patients applied

Trial Officials

Maurizio Degiuli, Professor

Principal Investigator

University of Turin, Department of Oncology

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials